You are viewing the site in preview mode
Skip to main content
|
Factors
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
B value
|
p value
|
B value (95% CI)
|
p value
|
|---|
|
Sex (M/F)
|
1.278
|
0.072
|
N.A.
|
N.A.
|
|
Age [y] (≤65/> 65)
|
− 1.225
|
0.080
|
N.A.
|
N.A.
|
|
Neoadjuvant therapy (N/Y)
|
4.444
|
< 0.001
|
3.562 (1.178,5.947)
|
0.003
|
|
Tumor size [cm] (≤3/> 3)
|
3.381
|
< 0.001
|
1.947 (0.353,3.540)
|
0.017
|
|
T stage (T≤2/T3–4)
|
2.863
|
< 0.001
|
−1.419 (−3.722,0.884)
|
0.227
|
|
Lymphovascular emboli (N/Y)
|
1.231
|
0.084
|
N.A.
|
N.A.
|
|
Perineural invasion (N/Y)
|
2.377
|
0.001
|
0.871 (−0.830,2.572)
|
0.316
|
|
Tumor deposit (N/Y)
|
1.959
|
0.182
|
N.A.
|
N.A.
|
|
pN stage (N0/N+)
|
3.474
|
< 0.001
|
1.528 (− 0.460,3.516)
|
0.132
|
|
M stage (M0/M1)
|
0.123
|
0.950
|
N.A.
|
N.A.
|
|
AJCC stage (I/II-IV)
|
3.854
|
< 0.001
|
2.073 (−0.755,4.900)
|
0.151
|
|
Extent of lymphadenectomy (D1+/D2)
|
3.248
|
< 0.001
|
0.037 (−1.995,2.068)
|
0.972
|
|
Microsatellite status (MSS/MSI-H)
|
2.720
|
0.005
|
2.468 (0.563,4.374)
|
0.011
|
- CI confidence interval
- N.A. not applicable
- MSI-H microsatellite instability-high
- MSS microsatellite stability